Myogenic palsies Flashcards
what are examples of myogenic palsies
chronic progressive external ophthalmoplegia (cpeo)
cpeo+
myotonic dystrophy
ocular myositis
tumours of muscle e.g. rhabdomyoscarm
define myogenic palsy
a primary disease of a muscle causing it to underact
the weakness of ocular movement is due to a primary problem affecting the muscle itself rather than one disrupting the nerve supply or causing mechanical restriction
what is cpeo
chronic progressive external ophthalmoplegia
progressive bilateral ptosis usually procecing motility loss
progressive symmetrical loss of motility
eyes become virtually immobile
obicularis weakness
bells phenomena often affected
fibrotic changes may occur later
aetiology of cpeo
mitchondrial ocular disorders
deletion of mitochondrial dna
age of onset - early 2os
genetics
sporadic but autosomonal dominant form does occur
the ocular characteristics develop - isolation cpeo
association with multi system defects = cpeo+
what is cpeo+
opthalmoloplegi +
retinal pigmentary changes (retinitis pigmentosa)
cardiac defects
deafness (cochlear epithelium metabolically active tissue)
cerebellar ataxia
peripheral neuropathy
impaired cognition (mental retardation)
endocrine dysfunction
reduced grey matter and cerebellar volumes
mtDNA and CPEO+
Higher levels of deleted mtDNA in a wider range of tissue
Multiple mtDNA deletions in skeletal muscle, which are 2° to a nuclear genetic defect affecting mtDNA maintenance, replication or repair
Karens Sayre syndrome
Onset - by age 20 (typically present in childhood)
Ocular
Ophthalmoplegia
Bilateral ptosis
Orbicularis weakness
Bell’s phenomenon affected & difficulty closing lids
Retinal pigmentary changes
General (Higher levels of deleted mtDNA in a wider range of tissues)
Heart block - cardiac conduction defects
Cerebellar ataxia
High cerebrospinal fluid
MRI study in CPEO
MRI study
A significant reduction in EOM volume in the CPEO group compared to normal for all 4 recti muscles. Approx 10 in each group
Reduction ranged between 24-40%
There was a significant reduction in extraocular muscle volumes in the CPEO group compared with normal controls for all four recti muscles , ranging from 24.7% to 40.2% ( Figure 2).
= EOM atrophy (Myogenic palsy)
EOMs affected in CPEO
it is a mitochondria disorder
deletion of the different lengths of mtdna defective mitochondrial function
eom have a higher mitochondrial volume than other Skelton volume
Mitochondrial DNA encodes for essential components of the respiratory chain. Deletions of various lengths of mtDNA results in defective mitochondrial function, particularly in highly oxidative tissues (eg, muscle, brain, heart). Extraocular muscles are affected preferentially because their fraction of mitochondrial volume is several times greater than that of other skeletal muscle.[5,6] and therefore affected
what is found for both neurogenic and myogenic palsies
A
degeneration of brainstem
increased latency of blink response
restriction of voluntary eye movements
abnormal mri
muscle co contraction
what is a common MRI finding for both cpeo and cpeo+
significant reduction in grey matter and cerebellar volumes for both types of cpeo patients
what structures are affected in cpeo +
muscle and peripheral nerves
what are the differential diagnosis for cpeo
cfeom - congenital fibrosis for the eom
myasthenia gravis
3rd nerve palsy
graves rbitopathy
oclopharangeal dystrophy
what is ocularpharanogeal dystrophy
Inheritance: autosomal dominant
Aetiology: caused by short triplet repeat expansion
Characteristics
Onset - 5th decade of life
Pharangeal weakness - difficulty swallowing
Facial and limb weakness
Pain in proximal muscles
Ocular (mimics CPEO)
Progressive bilateral ptosis
OM, orbicularis and Bells Phenomenon usually intact – may develop limitation of elevation later
Saccades - reduced
what is necessary for the differential diagnosis of cpeo
Onset
Natural history
Saccadic velocities ↓
CT / MRI - atrophic muscles
Muscle biopsy - (skeletal muscle/ eye muscle)
Histology for ‘ragged red fibres’
Genetic testing for mtDNA deletions
is muscle biopsy conclusive evidence for the presence of cpeo
A
Muscle biopsy provides important clues to the diagnosis of patients presenting with CPEO.
However, in about 40% of patients, histological studies may not be diagnostic of mitochondrial myopathy.
Histological studies should be combined with genetic studies for the definitive diagnosis of CPEO syndrome.
how is cpeo managed
Nutritional supplements explored to increase mitochondrial function
Currently no effective evidence-based disease modifying therapy identified (Pfeffer and Chinnery 2013)
Gene therapy
no cases treated with this as yet
Referral to…
Neurologist, Cardiologist – (ECG important to rule out cardiac abnormalities), Audiologist, Dysphagia (difficulty swallowing) – refer to appropriate specialist, Endocrinologist